Long-term clinical outcome in patients with severeleft ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias;Evolução clínica a longo-prazo em sobreviventes de taquidisritmias ventriculares com disfunção sistólica grave do ventrículo esquerdo submetidos a implantação de cardioversor-desfibrilhador

Revista Portuguesa de Cardiologia

Volumn 24, Issue 4, 2005, Pages 487-498

  Pelicano, Nuno ^a   Oliveira, Mario ^a   Da Silva, Nogueira ^a   Antunes, Eduardo ^a   Santos, Sofia ^a   Conceição, José Manuel ^a   Roquette, José ^a   Quininha, Jorge ^a  

^a NONE

Author keywords

Implantable cardioverter defibrillator; Left ventricular systolic dysfunction; Sudden death

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CANDESARTAN; CAPTOPRIL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; LISINOPRIL; LOSARTAN; METOPROLOL; NITRATE; PERINDOPRIL; RAMIPRIL; VALSARTAN;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART RATE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; HYPERTENSION; LONG TERM CARE; MALE; PARAMETER; PERIOPERATIVE PERIOD; PROGNOSIS; SECONDARY PREVENTION; SHOCK; SUDDEN DEATH; SURGICAL MORTALITY; SURVIVAL; TREATMENT OUTCOME;

DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 20444461243     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Giannattasio B, Carlson M. Chapter 79. When to use implantable cardioverter defibrillators in heart failure. In: Braunwald E. Harrison's Advances in Cardiology. New York: McGraw-Hill 2003;500:08.
2. Sweeney MO. Sudden death in heart failure associated with reduced left ventricular function: substrates, mechanisms, and evidence-based management, part I. J Pacing Clin Electroph May 2001;24;5:871-85.
3. Timóteo AT, Adragão P, Morgado F et al. Cardioversor- Desfibrilhador Implantável: para além da eficácia. Rev Port Cardiol 2001;20(11):1071-85.
4. Pinski SL, Yao Q, Epstein AE et al. Determinants of outcome in patients with sustained ventricular tachyarrhythmias: the Antiarrhythmics Versus Implantable Defibrillators (AVID) study registry. Am Heart J 2000 May;139(5):804-13.
5. Karl-Heinz K, Cappato R, Siebels J, Ruppel R, for the CASH investigators. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. Circulation 2000;102:748-54.
6. Sheldon R, Connolly S, Krahn A et al., for the CIDS investigators. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy. Circulation 2000;101:0-1664.
7. Oseroff O, Retyk E, Bochoeyer A. Subanalyses of secondary prevention implantable cardioverter- defibrillator trials: Antiarrhythmics Versus Implantable Defibrillators (AVID), Canadian Implantable Defibrillator Study (CIDS) and Cardiac Arrest Study Hamburg (CASH). Curr Opin Cardiol 2004 Jan; 19(1):26-30.
8. Moss AJ, Zareba W, Hall WJ et al., for the MADIT II investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
9. Bardy GH, for the SCD-HeFT Investigators. ACC 2004 Sessions, Late Breaking Clinical Trial session.
10. Norris RM, Barnaby PF, Brandt PW et al. Prognosis after recovery from first acute myocardial infarction: determinants of reinfarction and sudden death. Am J Cardiol 1984 Feb 1;53(4):408-13.
11. Mukharji J, Rude RE, Poole WK et al. Risk factors for sudden death after acute myocardial infarction: two-year follow-up. Am J Cardiol 1984 Jul 1;54(1):31-6.
12. Cleland JG, Thackray S, Goodge L et al. Outcome studies with device therapy in patients with heart failure. J Cardiovasc Electrophysiol, 2002 Jan;13(1 Suppl):S73-91.
13. Bardy GH, Lee KL, Mark DB, et al., for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
14. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-2158.
15. Narasimhan C, Dhala A, Axtell K et al. Comparison of outcome of implantable cardioverter- defibrillator implantation in patients with severe versus moderately severe left ventricular dysfunction secondary to atherosclerotic coronary artery disease. Am J Cardiol 1997;80:1305-08.
16. Brooks R, McGovern BA, Garan H, Ruskin JN. Current treatment of patients surviving out-of-hospital cardiac arrest. JAMA 1991 Feb 13;265(6):762-68.
17. Di Carli MF, Davidson M, Little R et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994 Mar 15;73 (8): 527-33.
18. Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure (COMPANION Trial). N Engl J Med 2004;350:2140-50.
19. Kim SG, Fisher JD, Choue CW et al. Influence of left ventricular function on outcome of patients treated with implantable defibrillators. Circulation-Abstracts 1998;85(4): 1304.
20. Nanthakumar K, Dorian P, Paquette M et al. Is inappropriate implantable defibrillator shock therapy predictable? J Interv Car Electrophysiol 2003 Jun;8(3):215-20.
21. Vester EG, Dees H, Dobran I et al. 14-year experience with implantable cardioverter-clefibrillators: determination of prognosis and discharge behavior. Z Kardiol 2000;89 Suppl 3:194-205.
22. Pitschner HF, Neuzner J, Himmrich E et al. Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term results. J Interv Card Electrophysiol 1997 Nov;1(3):211-20.